GRAIL, LLC (GRAL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, GRAIL, LLC (GRAL) has a cash flow conversion efficiency ratio of -0.025x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-63.78 Million) by net assets ($2.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GRAIL, LLC - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how GRAIL, LLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of GRAIL, LLC for a breakdown of total debt and financial obligations.
GRAIL, LLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GRAIL, LLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Globant SA
NYSE:GLOB
|
0.041x |
|
Zymeworks Inc. Common Stock
NASDAQ:ZYME
|
-0.098x |
|
Hunan Valin Wire & Cable Co Ltd
SHE:001208
|
-0.004x |
|
Formula Systems (1985) Ltd
F:FSY
|
N/A |
|
Beijing Yuanliu Hongyuan Electronic Technology Co Ltd
SHG:603267
|
-0.031x |
|
Zhejiang Runtu Co Ltd
SHE:002440
|
0.032x |
|
Dongsuh
KO:026960
|
0.006x |
|
Innovex International, Inc
NYSE:INVX
|
0.049x |
Annual Cash Flow Conversion Efficiency for GRAIL, LLC (2018–2025)
The table below shows the annual cash flow conversion efficiency of GRAIL, LLC from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see GRAIL, LLC (GRAL) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.58 Billion | $-299.01 Million | -0.116x | +49.69% |
| 2024-12-31 | $2.50 Billion | $-577.16 Million | -0.231x | -41.09% |
| 2023-12-31 | $3.65 Billion | $-595.80 Million | -0.163x | -35.25% |
| 2022-12-31 | $4.65 Billion | $-561.31 Million | -0.121x | -65.57% |
| 2021-12-31 | $9.43 Billion | $-688.13 Million | -0.073x | +82.33% |
| 2020-12-31 | $561.84 Million | $-232.00 Million | -0.413x | +7.51% |
| 2019-12-31 | $550.53 Million | $-245.79 Million | -0.446x | -28.09% |
| 2018-12-31 | $600.37 Million | $-209.26 Million | -0.349x | -- |
About GRAIL, LLC
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The compan… Read more